Onchocerciasis (river blindness)

Cutis

Volumn 72, Issue 4, 2003, Pages 297-302+296

  Borup, Lance H ^a,e   Peters, John S ^b   Sartori, Christopher R ^c,d  

^a Osteopathic Medical Center of Texas   (United States)

^b MARTIN ARMY COMMUNITY HOSPITAL   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNITED STATES AIR FORCE ACADEMY   (United States)

^e USAF   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; HYDROXYZINE; IVERMECTIN;

ADULT; AFRICA; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; EXCISION; FILARIA; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERSENSITIVITY; LABORATORY TEST; MALE; MICROFILARIA; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PHYSICAL EXAMINATION; PRURITUS; SKIN BIOPSY; SKIN NODULE;

ADULT; ANIMALS; ANTHELMINTICS; ANTIPARASITIC AGENTS; BIOPSY; BUTTOCKS; HUMANS; IVERMECTIN; MALE; MICROFILARIA; ONCHOCERCIASIS, OCULAR; SKIN DISEASES, PARASITIC;

EID: 0242438548     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. World Health Organization. Onychocerciasis (river blindness) fact sheet no. 95. Available at: http://who.int/inf-fs/en/fact095.html. Accessed September 8, 2003.
2. Freeman D. Onchocerciasis. In: Guerrant RL, Walker DH, Weller PF. Tropical Infectious Diseases: Principles, Pathogens, and Practice. 1st ed. Philadelphia, Pa: Churchill Livingstone; 1999:873-886.
3. Burnham G. Onchocerciasis. Lancet. 1998;351:1341-1346.
4. Duke BO. Human onchocerciasis - an overview of the disease. Acta Leiden. 1990;59:9-24.
5. Vuong PN, Bain O, Cabaret J, et al. Forest and savanna onchocerciasis: comparative morphometric histopathology of skin lesions. Trop Med Parasitol. 1988;39:105-110.
6. Ottesen EA. Immune responsiveness and the pathogenesis of human onchocerciasis. J Infect Dis. 1995;171:659-671.
7. Elgart ML. Onchocerciasis. Dermatol Clin. 1989;7:322-328.
8. Greene BM. Modern medicine versus an ancient scourge: progress toward control of onchocerciasis. J Infect Dis. 1992;166:15-21.
9. Chan CC, Nussenblatt RB, Kim MK, et al. Immunopathology of ocular onchocerciasis, 2: anti-retinal autoantibodies in serum and ocular fluids. Ophthalmology. 1987;94:439-443.
10. McMahon JE, Simonsen PE. Filariasis. In: Cook GC, ed. Manson's Tropical Diseases. 20th ed. London, England: WB Saunders Co; 1996:1338-1351.
11. Taylor HR, Munoz B, Keyvan-Larijani E, et al. Reliability of detection of microfilariae in skin snips in the diagnosis of onchocerciasis. Am J Trop Med Hyg. 1989;41:467-471.
12. Zimmerman PA, Guderian RH, Aruajo E, et al. Polymerase chain reaction-based diagnosis of onchocerca volvulus infection: improved detection of patients with onchocerciasis. J Infect Dis. 1994;169:686-689.
13. Gibson DW, Heggie C, Connor DH. Clinical and pathologic aspects of onchocerciasis. Pathol Annu. 1980;15(pt 2):195-240.
14. Albiez EJ, Buttner DW, Duke BO. Diagnosis and extirpation of nodules in human onchocerciasis. Trop Med Parasitol. 1988;39(suppl 4):331-346.
15. Leichsenring M, Troger J, Nelle M, et al. Ultrasonographical investigations of onchocerciasis in Liberia. Am J Trop Med Hyg. 1990;43:380-385.
16. Goa KL, McTavish D, Clissold SP. Ivermectin: a review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs. 1991;42:640-658.
17. Mabey D, Whitworth JA, Eckstein M, et al. The effects of multiple doses of ivermectin on ocular onchocerciasis: a six year follow-up. Ophthalmology. 1996;103:1001-1008.
18. Vyungimana F, Newell E. Treatment of onchocerciasis with ivermectin (Province of Bururi, Burundi): parasitologic and clinical evaluation of different periodicities of treatment. Am J Trop Med Hyg. 1998;59:828-831.
19. De Sole G, Remme J, Awadzi K, et al. Adverse reactions after mass treatment of onchocerciasis with ivermectin: combined results from 8 community trials. Bull World Health Organ. 1989;67:707-719.
20. Strote G, Bonow I, Kromer M, et al. Chemotherapy for onchocerciasis: results of in vitro experiments with promising new compounds. Trop Med Int Health. 1998;3:397-407.
21. Mectizan Donation Program. Highlights of the celebrations in Tanzania for the 15th anniversary of the Mectizan Donation Program and the 250 millionth treatment. Available at http://www.mectizan.org/celebrating.asp. Accessed September 8, 2003.